Changes in Beneficial Ownership · 4
Oncology Institute, Inc.
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-07-27
- Issuer
- Oncology Institute, Inc.
- Issuer CIK
- 0001799191
- Trading symbol
- TOI
Reporting owner 1
- Name
- Pacala Mark L
- Reporting owner CIK
- 0001321250
- Relationship
- Director
- Address
- C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-07-27 | A · Form 4[F1] | 30,120 | A | 0.00 | 286,881 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.↩ 1
Signature 1
- Signed
- /s/ Mark Hueppelsheuser, Attorney-in-Fact for Mark L. Pacala
- Date
- 2026-07-29
Company context
Current securities
Recent company filings
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 2, 2026
- Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementAug 21, 2026
- 144 filingAug 21, 2026
- 10-Q filingAug 6, 2026
- Results of Operations and Financial ConditionAug 6, 2026